Maduck Sean's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Oct 5, 2021
- Accession no.
- 0000899243-21-039272
- Filed
- Oct 5, 2021
- Trade date
- Oct 1-5, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $500.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maduck SeanCIK 0001698310 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Common Stock | MOption exerciseAcquired | +24,363 | $3.29 | +$80,154.27 | 64,387 | Direct | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −24,363 | $20.00F2 | −$487,260 | 40,024 | Direct | |
| Oct 5, 2021 | Common Stock | MOption exerciseAcquired | +637 | $3.29 | +$2,095.73 | 40,661 | Direct | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −637 | $20.00 | −$12,740 | 40,024 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Common Stock | MOption exerciseDisposed | −24,363 | $0.00 | $0 | 123,239 | Direct | |
| Oct 5, 2021 | Common Stock | MOption exerciseDisposed | −637 | $0.00 | $0 | 122,602 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.00 to $20.05 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.